Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), by Route of Administration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global Parkinson’s disease therapeutics market expected to generate around USD 5.28 billion by 2025, at a CAGR of around 10.6% between 2019 and 2025. Parkinson’s disease (PD) is a nervous system disorder that increases in severity with time. The disease is characterized by its bradykinesia, rigidity, tremor, and postural instability.

31-May-2019 | Number of pages: 110 | Report Code: ZMR-2858 | Report Format : | Status : Published

Analysis

Parkinson’s disease (PD) is a nervous system disorder that increases in severity with time. The disease is characterized by its bradykinesia, rigidity, tremor, and postural instability. Some of the most common symptoms of Parkinson’s disease include arms, hand, or leg tremors, problems associated with balancing and walking, stiff muscles, and slow physical movements. Other symptoms include constipation, trouble in swallowing, dementia, fixed or blank expressions, and speech disabilities. However, the exact cause causing the disease is still not known, but it generally affects the patients of the older age group, i.e., mostly more than 50 years in age.

The global Parkinson’s disease therapeutics market is likely to be driven by the launch of prominent pipeline drugs like ND0612H, Accordion Pill, APL-130277, P2B-001, etc., increasing research and development activities for the development of novel Parkinson’s disease therapeutic drugs, and rising Parkinson’s disease incidences. The incidence rate of Parkinson’s disease increases with growing age. Additionally, the world’s population above 65 years is likely to increase from 6.8% in 2000 to almost 17% by 2050, which is a major driver for Parkinson’s disease therapeutics market growth.

Global Parkinson’s Disease Therapeutics Market

Based on drug class, the market includes dopamine agonists, catechol-o-methyltransferase (COMT) inhibitors, anticholinergic drugs, levodopa combination, monoamine oxidase B (MAO-B) inhibitors, and others. Based on route of administration, the market includes transdermal, oral, subcutaneous, and intestinal infusion. The oral segment held a significant share of the market in 2018 globally. The distribution channel of the Parkinson’s disease therapeutics market is fragmented into retail pharmacy, online sales, and hospital pharmacy. The retail pharmacy segment dominated the global market in 2018 and is projected to hold a significant market share in the future.

By region, Europe holds a major share of the global Parkinson’s disease therapeutics market followed by the North American region. Favorable medical reimbursement policies, rising funding and grants for research, high Parkinson’s disease prevalence, and growing awareness about the disease are contributing to the European Parkinson’s disease therapeutics market. In the North America market, alone there are more than 10 different drugs under phase III clinical pipeline studies for treating different symptoms of Parkinson’s disease in the U.S. alone. The Asia Pacific Parkinson’s disease therapeutics market is likely to show a moderate CAGR, owing to a large base of the elderly population suffering from Parkinson’s disease, particularly in China and Japan.

Some players of the global Parkinson’s disease therapeutics market are Teva Pharmaceutical, STADA Arzneimittel, Impax Laboratories, Novartis, F. Hoffmann-La Roche, Merck & Co., UCB Inc., GlaxoSmithKline, AbbVie, and Valeant Pharmaceuticals International.


Related Reports

Tissue Engineering Market by Application (Gynecology, Cell Banking & Cord blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5337 | Report Format:

The report covers forecast and analysis for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering ma...Read More

Robotic Prosthetic Market by Extremity (Upper Body Prosthetics and Lower Body Prosthetics), and Technology (Myoelectric Prosthetics and MPC Prosthetics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5336 | Report Format:

The report covers forecast and analysis for the robotic prosthetic market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the robotic prosthetic ...Read More

Long-Term Care Market by Service (Hospice, Home Healthcare, Assisted Living Facilities, Nursing care, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5335 | Report Format:

The report covers forecast and analysis for the long-term care market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the long-term care market alo...Read More

Leprosy Treatment Market by Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), by Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Mar-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5334 | Report Format:

The report covers forecast and analysis for the Leprosy Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Leprosy Treatment ma...Read More

Hunter Syndrome Treatment Market by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5333 | Report Format:

The report covers forecast and analysis for the hunter syndrome treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the hunter syndrom...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.